RU2017112984A - Энергетические напитки и другие пищевые добавки, производимые из спиртных напитков на основе агавы - Google Patents
Энергетические напитки и другие пищевые добавки, производимые из спиртных напитков на основе агавы Download PDFInfo
- Publication number
- RU2017112984A RU2017112984A RU2017112984A RU2017112984A RU2017112984A RU 2017112984 A RU2017112984 A RU 2017112984A RU 2017112984 A RU2017112984 A RU 2017112984A RU 2017112984 A RU2017112984 A RU 2017112984A RU 2017112984 A RU2017112984 A RU 2017112984A
- Authority
- RU
- Russia
- Prior art keywords
- mao
- composition
- composition according
- distillate
- ethanol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12H—PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES
- C12H3/00—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages
- C12H3/04—Methods for reducing the alcohol content of fermented solutions or alcoholic beverage to obtain low alcohol or non-alcoholic beverages using semi-permeable membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/02—Food
- G01N33/14—Beverages
- G01N33/146—Beverages containing alcohol
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/904—Oxidoreductases (1.) acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
- G01N2333/90605—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4)
- G01N2333/90633—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general
- G01N2333/90638—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
Claims (26)
1. Композиция, содержащая ингибирующие моноаминооксидазу (MAO) соединения и изготовленная посредством удаления этанола из спиртного напитка, произведенного из агавы, способом, который сохраняет летучие соединения, не представляющие собой этанол.
2. Композиция по п. 1, в которой спиртной напиток представляет собой дистиллят.
3. Композиция по п. 1, в которой способ представляет собой обратный осмос.
4. Композиция по п. 1, в которой спиртной напиток представляет собой дистиллят, который изготавливают, осуществляя следующие стадии:
a) нагревание стеблей кактуса агавы для гидролиза сложных сахаров;
b) резание и дробление нагретых стеблей для выделения сиропа;
c) разбавление вышеупомянутого сиропа водой до уровня от 12 до 14° BRIX и засевание дрожжами;
d) брожение засеянного разбавленного сиропа для получения продукта брожения; и
e) перегонка продукта брожения для получения дистиллята.
5. Композиция по п. 4, в которой стадия (a) осуществляется посредством обработки в автоклаве.
6. Композиция по п. 4, в которой стадия (b) осуществляется в режущем и дробильном устройстве.
7. Композиция по п. 4, в которой способ на стадии (d) включает брожение при температуре от комнатной до 30°C в присутствии дрожжей Saccharomyces cerevisiae и Kloeckera africana.
8. Композиция по п. 4, в которой стадия (e) осуществляется до тех пор, пока дистиллят не достигает концентрации этанола, составляющей, по меньшей мере, от 38 до 40 об.%.
9. Пищевой продукт или напиток, который содержит композицию по п. 1.
10. Пищевой продукт или напиток, который содержит композицию по п. 2.
11. Способ лечения состояний, отличающихся чрезмерной активностью моноаминооксидазы (MAO), причем данный способ включает введение нуждающемуся в этом пациенту эффективного для такого лечения количества композиции по п. 1.
12. Способ по п. 11, в котором вышеупомянутое состояние представляет собой депрессию или болезнь Паркинсона.
13. Способ лечения состояний, отличающихся чрезмерной активностью моноаминооксидазы (MAO), причем данный способ включает введение нуждающемуся в этом пациенту эффективного для такого лечения количества пищевого продукта или напитка по п. 9.
14. Способ анализа ингибиторов MAO в присутствии этанола, причем данный способ предусматривает включение алкогольдегидрогеназы и NAD в вышеупомянутый анализ.
15. Способ по п. 14, который включает следующие стадии:
a) добавление в анализируемый образец эффективного для субстрата количества дигидробромида кинурамина вместе с никотинамидадениндинуклеотидом и алкогольдегидрогеназой;
b) добавление MAO A и/или MAO B;
c) инкубация при 37°C;
d) прекращение реакции посредством сильного основания и
e) оценка результатов при длине волны возбуждения 310 нм и длине волны излучения 405 нм.
16. Система оценки произведенных из агавы спиртных напитков, в которой каждый напиток получает позицию на шкале качества на основании содержания в нем ингибиторов MAO A и/или ингибиторов MAO B.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462071179P | 2014-09-16 | 2014-09-16 | |
| US62/071,179 | 2014-09-16 | ||
| US201562231592P | 2015-07-10 | 2015-07-10 | |
| US62/231,592 | 2015-07-10 | ||
| PCT/US2015/050509 WO2016044473A1 (en) | 2014-09-16 | 2015-09-16 | Energy drinks and other nutritional aids derived from agave-based spirits |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017112984A true RU2017112984A (ru) | 2018-10-17 |
| RU2017112984A3 RU2017112984A3 (ru) | 2019-09-16 |
| RU2742610C2 RU2742610C2 (ru) | 2021-02-09 |
Family
ID=55453705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017112984A RU2742610C2 (ru) | 2014-09-16 | 2015-09-16 | Энергетические напитки и другие пищевые добавки, производимые из спиртных напитков на основе агавы |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US10195163B2 (ru) |
| EP (1) | EP3194557B1 (ru) |
| JP (3) | JP6687626B2 (ru) |
| KR (1) | KR20170074863A (ru) |
| CN (1) | CN107250340B (ru) |
| AU (3) | AU2015317751B2 (ru) |
| BR (1) | BR112017005328B1 (ru) |
| CA (1) | CA2961608C (ru) |
| CY (1) | CY1123421T1 (ru) |
| DK (1) | DK3194557T3 (ru) |
| ES (1) | ES2818097T3 (ru) |
| HK (1) | HK1244834A1 (ru) |
| HR (1) | HRP20201466T1 (ru) |
| HU (1) | HUE051469T2 (ru) |
| LT (1) | LT3194557T (ru) |
| MA (1) | MA39468B1 (ru) |
| MX (1) | MX2017003554A (ru) |
| PL (1) | PL3194557T3 (ru) |
| PT (1) | PT3194557T (ru) |
| RS (1) | RS60851B1 (ru) |
| RU (1) | RU2742610C2 (ru) |
| SI (1) | SI3194557T1 (ru) |
| WO (1) | WO2016044473A1 (ru) |
| ZA (1) | ZA201702165B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107250340B (zh) * | 2014-09-16 | 2021-05-07 | 罗伯特·布洛西亚 | 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物 |
| WO2018187628A1 (en) | 2017-04-05 | 2018-10-11 | Roar Holding, Llc | Improved method for isolation of mao inhibitors from tequila or other distilled agave fermentation products |
| CN109370848B (zh) * | 2018-11-05 | 2022-03-15 | 福建农林大学 | 一种红曲龙舌兰酒的加工方法 |
| CA3121090A1 (en) | 2018-11-26 | 2020-06-04 | Roar Holding Llc | Methods to improve beverage quality |
| US11839622B1 (en) | 2020-01-15 | 2023-12-12 | Randall Lewarchik | Consumable nutraceutical composition |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6091997A (ja) * | 1983-10-22 | 1985-05-23 | Wako Pure Chem Ind Ltd | モノアミンオキシダ−ゼ活性の測定方法 |
| US4612196A (en) * | 1984-08-23 | 1986-09-16 | Miller Brewing Company | Preparation of low alcohol beverages by reverse osmosis |
| US5262162A (en) | 1991-09-06 | 1993-11-16 | Merz & Co. Gmbh & Co. | Cerebral-activating extract |
| US6506430B1 (en) * | 1995-07-21 | 2003-01-14 | Brown-Forman Corporation | Oak aged alcoholic beverage extract and accelerated whisky maturation method |
| AU770309B2 (en) * | 1998-06-05 | 2004-02-19 | Regent Court Technologies | Monoamine oxidase (MAO) inhibitors and uses thereof |
| JP4319735B2 (ja) * | 1999-03-12 | 2009-08-26 | 丸善製薬株式会社 | モノアミンオキシダーゼ阻害剤および飲食物 |
| BRPI0801239A2 (pt) * | 2008-04-01 | 2009-11-17 | Ache Lab Farmaceuticos Sa | uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase |
| US20100178411A1 (en) * | 2009-01-13 | 2010-07-15 | Alma Imports, Inc. | Agave-plant-based composition of matter and methods of use |
| US8658236B2 (en) * | 2009-08-21 | 2014-02-25 | Deuteria Beverages, Llc | Alcoholic compositions having a lowered risk of acetaldehydemia |
| CN103119172B (zh) | 2010-06-18 | 2016-05-11 | 布特马斯先进生物燃料有限责任公司 | 在提取发酵中用于醇移除的来源于油的提取溶剂 |
| CA2783847C (en) * | 2012-07-24 | 2014-09-30 | Luc Hobson | Reduced calorie beverage or food product and process and apparatus for making same |
| US8609162B2 (en) * | 2012-10-04 | 2013-12-17 | Invivo Beverages Llc | Integrated neuromodulation system for mood enhancement of a living human subject |
| CN107250340B (zh) * | 2014-09-16 | 2021-05-07 | 罗伯特·布洛西亚 | 源自基于龙舌兰的烈酒的能量饮品和其他营养辅助物 |
-
2015
- 2015-09-16 CN CN201580062032.7A patent/CN107250340B/zh active Active
- 2015-09-16 RS RS20201090A patent/RS60851B1/sr unknown
- 2015-09-16 LT LTEP15843033.0T patent/LT3194557T/lt unknown
- 2015-09-16 BR BR112017005328-4A patent/BR112017005328B1/pt not_active IP Right Cessation
- 2015-09-16 US US14/856,438 patent/US10195163B2/en active Active
- 2015-09-16 WO PCT/US2015/050509 patent/WO2016044473A1/en active Application Filing
- 2015-09-16 AU AU2015317751A patent/AU2015317751B2/en active Active
- 2015-09-16 KR KR1020177009171A patent/KR20170074863A/ko not_active Application Discontinuation
- 2015-09-16 EP EP15843033.0A patent/EP3194557B1/en active Active
- 2015-09-16 JP JP2017534899A patent/JP6687626B2/ja active Active
- 2015-09-16 SI SI201531346T patent/SI3194557T1/sl unknown
- 2015-09-16 PT PT158430330T patent/PT3194557T/pt unknown
- 2015-09-16 PL PL15843033T patent/PL3194557T3/pl unknown
- 2015-09-16 MX MX2017003554A patent/MX2017003554A/es unknown
- 2015-09-16 DK DK15843033.0T patent/DK3194557T3/da active
- 2015-09-16 HU HUE15843033A patent/HUE051469T2/hu unknown
- 2015-09-16 CA CA2961608A patent/CA2961608C/en active Active
- 2015-09-16 RU RU2017112984A patent/RU2742610C2/ru active
- 2015-09-16 ES ES15843033T patent/ES2818097T3/es active Active
- 2015-09-16 MA MA39468A patent/MA39468B1/fr unknown
-
2017
- 2017-03-28 ZA ZA2017/02165A patent/ZA201702165B/en unknown
-
2018
- 2018-03-28 HK HK18104268.7A patent/HK1244834A1/zh unknown
-
2019
- 2019-02-01 US US16/265,713 patent/US11160774B2/en active Active
-
2020
- 2020-02-11 AU AU2020200964A patent/AU2020200964A1/en not_active Abandoned
- 2020-04-02 JP JP2020066796A patent/JP7212001B2/ja active Active
- 2020-09-10 CY CY20201100857T patent/CY1123421T1/el unknown
- 2020-09-14 HR HRP20201466TT patent/HRP20201466T1/hr unknown
-
2021
- 2021-09-16 AU AU2021232783A patent/AU2021232783B2/en active Active
- 2021-10-29 US US17/515,297 patent/US20220047531A1/en active Pending
-
2023
- 2023-01-12 JP JP2023002861A patent/JP2023052345A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017112984A (ru) | Энергетические напитки и другие пищевые добавки, производимые из спиртных напитков на основе агавы | |
| Cappello et al. | Linking wine lactic acid bacteria diversity with wine aroma and flavour | |
| Tofalo et al. | Influence of organic viticulture on non-Saccharomyces wine yeast populations | |
| Schopp et al. | Metabolism of nonesterified and esterified hydroxycinnamic acids in red wines by Brettanomyces bruxellensis | |
| Tofalo et al. | Detection of Brettanomyces spp. in red wines using real‐time PCR | |
| Sánchez et al. | Population dynamics of lactic acid bacteria during spontaneous malolactic fermentation in industrial cider | |
| Filteau et al. | Maple sap predominant microbial contaminants are correlated with the physicochemical and sensorial properties of maple syrup | |
| Bovo et al. | Aptitude of Saccharomyces yeasts to ferment unripe grapes harvested during cluster thinning for reducing alcohol content of wine | |
| JP2017529102A5 (ru) | ||
| Mangwanda et al. | Processes, challenges and optimisation of rum production from molasses—A contemporary review | |
| Piraine et al. | Isolation of wild yeasts from Olympic National Park and Moniliella megachiliensis ONP131 physiological characterization for beer fermentation | |
| Mortazavian et al. | The effect of Saccharomyces strain and fermentation conditions on quality prameters of non-alcoholic beer | |
| Dhanaseeli et al. | Studies of ethanol production from different fruit wastes using Saccharomyces cerevisiae | |
| Tantikachornkiat | The initiation of alcoholic and/or malolactic fermentations: their effect on microbes conducting Chardonnay wine fermentation and on the resulting sensorial wine profile | |
| Cartwright | Characterization, Vectors and Control of the Wine Spoilage Yeast, Brettanomyces bruxellensis | |
| Morgan | The effect of sulfur dioxide and alternative fermentation techniques on the microbial communities and sensory profiles of wine | |
| Palma | Isolation, identification and assessment of the potential of Saccharomyces and non-Saccharomyces strains for craft beer production | |
| González Benito | Application of molecular techniques for identification and ennumeration of acetic acid bacteria | |
| Sarba et al. | Research of different adjuvants and yeast dosages in honey fermentation process | |
| Leonardelli | Factors Affecting 4-Ethylphenol Production by the Wine Spoilage Yeast B. bruxellensis. | |
| Perez | Selection and optimization of acetic acid bacteria for d-gluconic acid production | |
| Deliu et al. | Researches concerning the evolution of wine microbiota during the spontaneous fermentation of red grapes juices | |
| NZ730510B2 (en) | Energy drinks and other nutritional aids derived from agave-based spirits | |
| Taran et al. | Isolation and obtain of pure yeast strains from the Puhoi vineyard for production of dry red wines | |
| WO2017068284A1 (fr) | Procédé d'analyse d'un échantillon pour la présence de levures de l'espèce brettanomyces bruxellensis résistantes aux sulfites et kit pour sa mise en œuvre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |